Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? - Wikidata - awgldk - TriplyDB

Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

http://www.wikidata.org/entity/Q35595547

about

Treatment for Barrett's oesophagus Barrett's oesophagus: from metaplasia to dysplasia and cancer Barrett's oesophagus and adenocarcinoma Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.Diagnosis and grading of dysplasia in Barrett's oesophagus.Optical detection and eradication of dysplastic Barrett's esophagus.Dysplasia in Barrett's esophagus: limitations of current management strategies.Predictors of progression in Barrett's esophagus: current knowledge and future directions Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.Barrett's oesophagus--a pathologist's view.Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists.Depth-resolved imaging of colon tumor using optical coherence tomography and fluorescence laminar optical tomography.Barrett's esophagus: endoscopic diagnosis.Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Biomarkers in Barrett's oesophagus and oesophageal adenocarcinoma.Radiofrequency ablation in the management of Barrett's esophagus: present role and future perspective.Progression of Barrett oesophagus: role of endoscopic and histological predictors.Surveillance for low-grade dysplastic Barrett's oesophagus: one size fits all?Minimally invasive esophagectomy for dysplastic Barrett's esophagus.Dysplasia in Barrett's oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible.TissueCypher(™): A systems biology approach to anatomic pathology.Epidemiology and biology of esophageal cancer.

P2860

Q24240701-C73BAF35-5BEC-45E6-9F84-37209112364E Q24685867-6CF2125A-D0E8-46FE-BDEF-DBE88D0CDF32 Q24791935-01F714D2-D730-4E1F-A830-F3BBED2557CD Q26825742-44D23A48-1EE4-4E48-AFE0-ECEEFA7BEE41 Q27027036-F840C9AE-FFE7-45F1-845B-44A111404403 Q31154028-F0173221-59BE-4725-B9C0-A9A1A2766AD2 Q34571587-FFB99957-CB1C-4FDB-A6FB-66B9F17D2EF7 Q35189335-9BC08097-EEB3-4007-BA23-74F152CA530F Q36077321-35B2FBCC-7E52-43FD-9184-EC8D0D45A797 Q36127891-6F407088-2E31-4887-8F58-350F16E8AFD5 Q36659456-23350C0B-BFD8-4B62-A512-51468EB41862 Q36699514-CB84E074-3689-4DB0-9F7B-5C1207EEA874 Q36803517-FBD33565-934F-4ED9-9E43-05251C4367A4 Q37359638-679B5FE6-2839-493D-A58E-849B5E3A42D0 Q37523763-B8D22F99-D1B5-4A3E-9CA2-3726E6FE1B8C Q37939279-81080D3D-E8AB-4BEC-BD40-10B9A691CF7D Q38005810-DAACD172-F584-4497-9692-F6DCC8CD6562 Q38089259-E29F2FF2-DA3C-40B4-A0CF-62A350A631EB Q38124891-246D3FAD-935B-4137-974E-FBD754E87CC6 Q38214785-CFC5534C-04E2-437D-B23E-510A9560B1F4 Q38219587-0ADED3AC-7841-4F62-A1B7-2870A8E17428 Q38242032-015F627B-D41F-4CF6-9568-D854280325C1 Q39966152-4152F200-C1C7-4CEB-8F69-2A5F3FCD393A Q40319118-9A34C5E3-F6CB-4C62-A769-C5275B6A2B33 Q43124349-5C8ADFD2-3268-445D-9137-F1D27584C460

P2860

Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy?

http://www.wikidata.org/entity/Q35595547

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@ast

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@en

type

label

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@ast

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@en

prefLabel

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@ast

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@en

P1433

Q35595547-86760A2E-4BB9-4CE1-B33F-BB533553E83B

P1476

Q35595547-2617A3F9-7DB5-479D-8617-D8FDA232A10A

P2093

Q35595547-DC0AACE4-1D11-47C7-8C34-27199AF8F521

Q35595547-E967139A-F3A9-4F17-AF29-750EBD79CF83

Q35595547-EB04130B-6F24-4BCD-B1D4-59D26D4890E7

P2860

Q35595547-13292B6F-8EE6-4038-9A29-367842346F44

Q35595547-181EE4DB-1324-45D6-8F4E-B40368C1E338

Q35595547-1A8DB810-05F1-4442-90F6-802588105462

Q35595547-3A88FF2B-5615-4E11-B838-1A38B90F278E

Q35595547-45D8D373-5943-493D-9039-F66C5B81B4A1

Q35595547-526D61D8-CD8C-4FCF-999D-05364BB1BAD6

Q35595547-543B5048-271D-42A9-B505-E107F084E8CA

Q35595547-5706A4A3-D90E-4E03-B1CC-33CBD9AF2F05

Q35595547-69A0F322-DAF8-4820-87ED-1E3071B4272D

Q35595547-6D98A955-A9F5-469A-9B01-9C04F9BE1FBF

P304

Q35595547-3D73F841-62B6-401B-807A-C51AC7BAAA88

P31

Q35595547-69938714-0C8C-45F2-AB6A-E6FAC85845DD

P356

Q35595547-2999F77A-436F-4231-A5C3-137F0A11F938

P407

Q35595547-BC2ED92A-C198-40E4-A2DE-686BC9BE27A7

P433

Q35595547-FC3D0D67-3D5D-4B87-B42E-CA43DA7DF222

P478

Q35595547-69C3E7C7-8069-49BF-A336-7657DD28EB77

P50

Q35595547-142A55FC-9131-4DFF-B0E7-E9F2D91FC9C6

P577

Q35595547-17287ADE-3850-4A97-8824-B67BF5970A52

P5875

Q35595547-EA9E6D26-6E46-4636-BF6C-9CD243BE300F

P698

Q35595547-B0A85FEE-1336-4865-8D75-9E499A701569

P921

Q35595547-B1472F1B-1D65-4F3B-B69C-4A42C5EA0F6F

P932

Q35595547-198A49B3-792B-4222-BDC7-9365C418CDB7

P356

P1433

P1476

Can extent of high grade dyspl ...... nocarcinoma at oesophagectomy?

@en

P2093

J R Goldblum

http://www.w3.org/2001/XMLSchema#string

M S Dar

http://www.w3.org/2001/XMLSchema#string

T W Rice

http://www.w3.org/2001/XMLSchema#string

P2860

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.

High-grade dysplasia in Barrett's esophagus: surveillance or operation?

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Superficial esophageal carcinoma.

Barrett's esophagus, dysplasia, and adenocarcinoma.

The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.

P304

486-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.52.4.486

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274430250

http://www.w3.org/2001/XMLSchema#string

P698

12631655

http://www.w3.org/2001/XMLSchema#string

P921

P932

1773616

http://www.w3.org/2001/XMLSchema#string